Trial intelligence / Profile preview

Treatment of EEG status epilepticus after cardiopulmonary resuscitation

NL-OMON50403Active, not recruiting

Sponsor
Rijnstate
Start
May 2014
Countries
1
01

Overview

Randomised, open-label trial in status epilepticus (SE) and hypoxic-ischemic encephalopathy (HIE) (2 arms), sponsored by Rijnstate. Primary endpoint: Neurological outcome at 3 months. Started May 2014; status: active, not recruiting.

02

Conditions

status epilepticus (SE)hypoxic-ischemic encephalopathy (HIE)

Beyond the preview

Go deeper on NL-OMON50403.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON50403.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call